© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Brimonidine Tartrate appears as a white to off-white crystalline powder, known for its application in ophthalmic solutions for reducing intraocular pressure in patients with glaucoma or ocular hypertension. The raw material derives from brimonidine, an alpha-2 adrenergic agonist, and tartaric acid, which combine to form the salt. The molecular formula ticks in at C11H10BrN5·C4H6O6, marking a defined structure combining two organic entities to create a stable salt. With a molecular weight around 442.24 g/mol, it stands out in the chemical catalog for its specificity within the pharmaceutical industry.
You can tell a lot about a material by its density and solubility. Brimonidine Tartrate shows a specific gravity between 1.7 and 1.8 g/cm³, setting expectations for how it behaves in laboratory and industrial scales. The substance dissolves freely in water and methanol, but hardly at all in nonpolar solvents like hexane or ether. Its crystalline nature might remind seasoned chemists of other tartaric acid salts, often forming fine, needle-like or pearly solids under controlled crystallization. Structural analysis using X-ray diffraction shows tight ionic bonding between the brimonidine cation and the tartrate anion—a factor impacting the compound’s reactivity and shelf stability.
The commercial form of Brimonidine Tartrate usually presents as a fine crystal or powder, though sometimes suppliers offer it in a slightly agglomerated, flaky consistency or dense pearls. Anyone preparing solutions for pharmaceutical use deals directly with these microcrystalline solids, weighing batches with precision. Stability remains robust under dry storage in sealed containers, but moisture or strong acids break it down, leading to loss of activity and safety hazards. Good practice dictates the use of gloves and protective eyewear throughout handling, as fine powder easily becomes airborne and can irritate mucous membranes.
The global trade in Brimonidine Tartrate falls under HS Code 2933990099, which includes other heterocyclic organic compounds. By sitting in this category, the raw material moves through customs channels requiring stringent documentation, reflecting its controlled-use status. This affects pricing, availability, and choice of suppliers, especially as international regulations around pharmaceutical ingredients tighten.
Experience in a chemistry lab quickly teaches respect for the safety data sheet. Brimonidine Tartrate, though primarily designed for therapeutic use, carries risks that need attention. The powder can cause moderate skin and eye irritation. Inhalation of dust or direct contact may trigger allergic reactions in sensitive individuals. Larger, unintentional ingestion leads to more serious symptoms—lowered blood pressure, drowsiness, and even respiratory depression. Working with the substance calls for ventilation, dust control, and reliable cleanup procedures. Chemical waste containing unused powder or contaminated gloves goes into designated hazardous bins, complying with local environmental rules.
Chemical industries get safer with investment in training, better labeling, and advanced protective gear. Labs storing Brimonidine Tartrate benefit from using automated powder-dispensing systems that reduce airborne exposure. Regulatory agencies, such as the FDA and EMA, require thorough traceability on the origin and lot number of each raw material shipment, cutting back the chance for contamination or counterfeit ingredients. Digital record-keeping assists companies in managing expiration, proper lot tracking, and effective recalls. Collaboration among manufacturers, labs, and logistics companies ensures raw materials like Brimonidine Tartrate retain safety and quality from production line to finished medication.
Materials like Brimonidine Tartrate highlight how much effort goes into the safety and reliability of pharmaceuticals. Each property—from the crystal structure to the density and handling requirements—sheds light on how companies turn basic chemicals into life-saving treatments. Personal experience has shown the value of clear information and transparent safety protocols each time a new batch arrives in the lab. Direct engagement, up-to-date documentation, and steady regulatory compliance bring peace of mind to both industry professionals and the patients ultimately depending on these compounds.
